InterCure Ltd. (NASDAQ:INCR) revealed on Friday that it will acquire Botanico Ltd., known as ISHI, in a move designed to strengthen its global cannabis portfolio and deliver entry into premium American cultivation technology and brand partnerships. The announcement arrives as the Trump administration signaled it is weighing the rescheduling of cannabis from Schedule I to Schedule III, a potential turning point that could reshape the industry for international operators such as InterCure. Through the acqui ...